1 completed, 1 terminated, 1 withdrawn. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 1, Terminated 1, Withdrawn 1 |
Follow beraprost: new trials by email Literature Review of beraprost trials Research Report on beraprost
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study With BPS-314d-MR-PAH-303 in Participants With Pulmonary Arterial Hypertension Esuberaprost, Placebo - Pulmonary Arterial Hypertension | Phase 3 | Terminated | Lung Biotechnology PBC | 112 | 2018-12-10 | 2020-09-07 |
| Beraprost-314d Added-on to Tyvaso® (BEAT) Beraprost Sodium 314d Modified Release Tablets, Placebo - Pulmonary Arterial Hypertension | Phase 3 | Completed | Lung Biotechnology PBC | 273 | 2013-05-31 | 2020-08-03 |
| A Multinational, Multicenter, Study to Assess the Efficacy and Safety of BPS-314d-MR in Subjects With Pulmonary Arterial Hypertension Currently Receiving Treatment With an Endothelin Receptor Antagonist and/or a Phosphodiesterase-5 Inhibitor Beraprost Sodium 314d Modified Release Tablets, Placebo - Pulmonary Arterial Hypertension | Phase 3 | Withdrawn | Lung Biotechnology PBC | 2011-11-01 | 2012-05-14 |
Pulmonary Arterial Hypertension (3) · Cardiovascular Diseases (1) · Familial Primary Pulmonary Hypertension (1) · Hypertension (1) · Hypertension, Pulmonary (1) · Lung Diseases (1) · Respiratory Tract Diseases (1) · Vascular Diseases (1)
Israel (2) · United States (2)